BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 404226)

  • 1. Absorption, excretion and tissue distribution of 2-pyridinethiol-1-oxide.
    Ziller SA
    Food Cosmet Toxicol; 1977 Feb; 15(1):49-54. PubMed ID: 404226
    [No Abstract]   [Full Text] [Related]  

  • 2. Absorption, distribution, and excretion of zinc pyridinethione in rabbits.
    Klaassen CD
    Toxicol Appl Pharmacol; 1976 Mar; 35(3):581-7. PubMed ID: 1265769
    [No Abstract]   [Full Text] [Related]  

  • 3. Percutaneous absorption of zinc pyridinethione in monkeys.
    Gibson WB; Calvin G
    Toxicol Appl Pharmacol; 1978 Mar; 43(3):425-37. PubMed ID: 418527
    [No Abstract]   [Full Text] [Related]  

  • 4. Absorption, distribution, metabolism, and excretion of furosemide in dogs and monkeys I: analytical methodology, metabolism, and urinary excretion.
    Yakatan GJ; Maness DD; Scholler J; Novick WJ; Doluisio JT
    J Pharm Sci; 1976 Oct; 65(10):1456-60. PubMed ID: 824434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SAFETY EVALUATION OF ZINC 2-PYRIDINETHIOL 1-OXIDE IN A SHAMPOO FORMULATION.
    SNYDER FH; BUEHLER EV; WINEK CL
    Toxicol Appl Pharmacol; 1965 May; 7():425-37. PubMed ID: 14288815
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolism of disodium ethane-1-hydroxy-1,1-diphosphonate (disodium etidronate) in the rat, rabbit, dog and monkey.
    Michael WR; King WR; Wakim JM
    Toxicol Appl Pharmacol; 1972 Apr; 21(4):503-15. PubMed ID: 4625817
    [No Abstract]   [Full Text] [Related]  

  • 7. The absorption, metabolism and excretion of disodium cromoglycate in nine animal species.
    Ashton MJ; Clark B; Jones KM; Moss GF; Neale MG; Ritchie JT
    Toxicol Appl Pharmacol; 1973 Nov; 26(3):319-28. PubMed ID: 4203381
    [No Abstract]   [Full Text] [Related]  

  • 8. Zinc pyridinethione: urinary metabolites of zinc pyridinethione in rabbits, rats, monkeys, and dogs after oral dosing.
    Jeffcoat AR; Gibson WB; Rodriguez PA; Turan TS; Hughes PF; Twine ME
    Toxicol Appl Pharmacol; 1980 Oct; 56(1):141-54. PubMed ID: 7444962
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound.
    Sugihara K; Morino A; Nomura A; Iida S; Sugiyama M
    Arzneimittelforschung; 1990 Jul; 40(7):800-5. PubMed ID: 2222556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cadmium administration on absorption, retention, and excretion of zinc-65 administered to rats.
    Oh SH; Whanger PD
    Environ Res; 1981 Oct; 26(1):130-5. PubMed ID: 7297526
    [No Abstract]   [Full Text] [Related]  

  • 11. The absorption, tissue distribution, and excretion of dodecyldimethylamine oxide (DDAO) in selected animal species and the absorption and excretion of DDAO in man.
    Rice DP
    Toxicol Appl Pharmacol; 1977 Mar; 39(3):377-89. PubMed ID: 854921
    [No Abstract]   [Full Text] [Related]  

  • 12. The excretion of (35S)dapsone and its metabolites in the urine, faeces and bile of the rat.
    Andoh BY; Renwick AG; Williams RT
    Xenobiotica; 1974 Sep; 4(9):571-83. PubMed ID: 4432536
    [No Abstract]   [Full Text] [Related]  

  • 13. Investigations on the absorption and distribution of trazodone or AF 1161 in rats, dogs and humans.
    Catanese B; Lisciani R
    Boll Chim Farm; 1970 Jun; 109(6):369-73. PubMed ID: 5484707
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolism of the hydroxyethylrutosides. II. Excretion and metabolism of 3',4',7-tri-O-(beta-hydroxyethyl) rutoside and related compounds in laboratory animals after parenteral administration.
    Barrow A; Griffiths LA
    Xenobiotica; 1974 Jan; 4(1):1-16. PubMed ID: 4207896
    [No Abstract]   [Full Text] [Related]  

  • 15. Bioavailability of indomethacin in man.
    Baer JE; Hucker HB; Duggan DE
    Ann Clin Res; 1974; 6(0):suppl 11:44-7. PubMed ID: 4211834
    [No Abstract]   [Full Text] [Related]  

  • 16. [The pharmacokinetics of 14C-zolimidine in rats].
    Schraven E; Trottnow D
    Arzneimittelforschung; 1976 Feb; 26(2):213-8. PubMed ID: 947201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transhepatic absorption and biliary excretion of insulin.
    Zingg W; Rappaport AM; Leibel BS
    Can J Physiol Pharmacol; 1987 Sep; 65(9):1982-7. PubMed ID: 3319114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methimazole: absorption, metabolism and excretion in the albino rat.
    Sitar DS; Thornhill DP
    J Pharmacol Exp Ther; 1973 Feb; 184(2):432-9. PubMed ID: 4688180
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies on anti-inflammatory agents. VI. Absorption, Excretion and metabolism of 2-amino-3-ethoxycarbonyl-6-benzyl(alpha-14C)-4,5,6,7-tetrahydrothieno(2,3-c)pyridine (14C-Y-3642) in mice].
    Imamura H; Matsui E; Kato Y
    Yakugaku Zasshi; 1970 Mar; 90(3):302-7. PubMed ID: 5464160
    [No Abstract]   [Full Text] [Related]  

  • 20. Distribution and excretion of 14C-cyclocytidine in experimental animals.
    El Dareer SM; White VM; Tillery K; Chen FP; Mellett LB; Hill DL
    Cancer Treat Rep; 1977 Aug; 61(5):805-14. PubMed ID: 70271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.